Sirolimus
NDC 59762-1001, SIROLIMUS, tablet, sugar coated, from Mylan Pharmaceuticals Inc..
- Product NDC
- 59762-1001
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET, SUGAR COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021110
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SIROLIMUS.5 mg/1
Pharmacologic classes
Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59762-1001-1 | 59762100101 | 100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1001-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5908cd1a-fc5a-462f-99ed-1d8983e253c9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=59762-1001NADAC price for package 59762100101
GET /v1/drugs/nadac/59762100101
Use it
Look up 59762-1001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59762-1001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.